NEW YORK (GenomeWeb News) – Monsanto today announced it has acquired some of the assets of genomics-based plant breeding firm Agradis, a little more than one year after the company was formed by J. Craig Venter's Synthetic Genomics and Mexican investment and management firm Plenus.

Included in the assets purchased by Monsanto are the Agradis name, its collection of microbes for improving crop productivity, and Agradis' R&D site in La Jolla, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.